On September 27, the British Trade and Investment Agency and the China Chamber of Commerce for the Import and Export of Chinese Medical and Health Products signed a memorandum of cooperation on Sino-British pharmaceutical and biopharmaceutical technology transfer in Beijing. The “China-UK Hand in Hand·Medicinal Innovation” Technology Transfer Forum was held on the same day as the important annual event of the China-UK Economic and Trade Joint Committee Medical Trade Investment Working Group. Robert Dave, Director of High-tech Industries, UK Trade and Investment Agency attended the event.

The Chinese and British sides will cooperate in the areas of technology transfer, modernization of Chinese medicine, revision of pharmacopoeia, innovation and technical cooperation, trade and investment information sharing, and establish policy discussions, standards development, technological innovation, and academic research for Chinese and British pharmaceutical companies and R&D institutions. The comprehensive service platform for exchanges, product demonstrations, project cooperation, and investment and financing linkages work together to promote the leap-forward development of bilateral trade, investment and R&D cooperation between China and the United Kingdom, promote industrial upgrading and create economic growth.

China and the UK are facing the establishment of partnerships between China and UK to promote biopharmaceutical growth, R&D and technology transfer of biopharmaceuticals, research and development of innovative TCM drugs, support for globalization of TCM, promotion of corporate development through technological innovation, and participation of TCM companies in international competition Questions and thoughts were exchanged, and it was considered that the meeting was a good start for Sino-British pharmaceutical innovation cooperation.

Since the establishment of the Sino-British Medical Trade Investment Working Group in 2007, it has carried out many excellent and fruitful activities and has achieved very good results in promoting Sino-British trade and investment cooperation and establishing a platform for Sino-British medical communication. As the Chinese leader of the working group, the Medical Insurance Association has launched the "Life Bridge" global online platform for the transfer of medical technology. With the help of online media and e-commerce, it has made every effort to build a Chinese-foreign medical technology trade and investment platform to meet the needs of Chinese and foreign pharmaceutical companies. The need for innovative product transfer.